Research Paper Volume 8, Issue 11 pp 3120—3130
Rapamycin treatment benefits glucose metabolism in mouse models of type 2 diabetes
Figure 2. Effect of rapamycin on body weight gain in 5 diabesity models. Rapamycin significantly reduces body weight gain in NcZ10, BKS-db/db, and TH strains, but not in KK-Ay or KK strains. P values are given for repeated measures MANOVA (n = 5–6 per strain/treatment group, except n = 11 for both NcZ10 groups). Note that the Y-axis scale for BKS-db/db is over a different 14-g span than the other 4 strains.